Latest Blood disorders Stories
The key to treating one of the most common types of human leukemia may lie within mutations in a gene called FLT3, according to new research led by physician-scientists at the University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center.
Around 80 percent of children with acute lymphoblastic leukemia (ALL) are now cured. With advancing treatment the cure rate may reach close to 90! Sounds promising right?
An international study found that bone marrow transplants are not the best option for some young patients with acute lymphoblastic leukemia (ALL) who fail to attain clinical remission after the initial weeks of intense chemotherapy known as induction therapy.
A novel anti-leukemia compound with little toxicity successfully treated zebrafish with T-cell acute lymphoblastic leukemia (T-ALL), suggesting its potential to become a new highly targeted therapy for humans – even those resistant to conventional therapies.
Researchers reporting in the April Cell Stem Cell, a Cell Press publication, have found a way to stop leukemia stem cells in their tracks.
The product, once available in the clinic, could be the first to hit a pathway that drives multiple types of lymphoma.
- Growing in low tufty patches.
More Images (1 images) »